Role of Na + /Ca 2+ Exchanger (NCX) in Glioblastoma Cell Migration (In Vitro).
Federico BrandaliseMartino RamieriEmanuela PastorelliErica Cecilia PrioriDaniela RattoMaria Teresa VenutiElisa RodaFrancesca TalpoPaola RossiPublished in: International journal of molecular sciences (2023)
Glioblastoma (GBM) is the most malignant form of primary brain tumor. It is characterized by the presence of highly invasive cancer cells infiltrating the brain by hijacking neuronal mechanisms and interacting with non-neuronal cell types, such as astrocytes and endothelial cells. To enter the interstitial space of the brain parenchyma, GBM cells significantly shrink their volume and extend the invadopodia and lamellipodia by modulating their membrane conductance repertoire. However, the changes in the compartment-specific ionic dynamics involved in this process are still not fully understood. Here, using noninvasive perforated patch-clamp and live imaging approaches on various GBM cell lines during a wound-healing assay, we demonstrate that the sodium-calcium exchanger (NCX) is highly expressed in the lamellipodia compartment, is functionally active during GBM cell migration, and correlates with the overexpression of large conductance K+ channel (BK) potassium channels. Furthermore, a NCX blockade impairs lamellipodia formation and maintenance, as well as GBM cell migration. In conclusion, the functional expression of the NCX in the lamellipodia of GBM cells at the migrating front is a conditio sine qua non for the invasion strategy of these malignant cells and thus represents a potential target for brain tumor treatment.
Keyphrases
- cell migration
- induced apoptosis
- cell cycle arrest
- endothelial cells
- endoplasmic reticulum stress
- signaling pathway
- poor prognosis
- climate change
- oxidative stress
- cell proliferation
- wound healing
- stem cells
- resting state
- risk assessment
- transcription factor
- cell therapy
- mass spectrometry
- protein kinase
- pi k akt
- bone marrow
- functional connectivity
- photodynamic therapy
- long non coding rna
- combination therapy